EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment

Lam-Duc-Huy Nguyen, Sheng-Liang Cheng, Yu-Ting Yen, Hsin-Mei Lee, Te-Haw Wu, Jane Wang, Shu-Yi Lin, Yunching Chen iD

Advanced Science · 2025-10 · 12 (37)

DOI: 10.1002/advs.202503238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.07.2025. Verfasst von Lam-Duc-Huy Nguyen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan. Hauptthemen laut MEDLINE: Dendritic Cells, Immunotherapy, Cryogels, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Health Research Institutes, National Tsing Hua University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer (TNBC) is an aggressive malignancy with high mortality and limited treatment options. While surgical resection removes the primary tumor, it often fails to prevent recurrence or metastasis, and despite the promise of immunotherapy, response to immune checkpoint blockade remains poor. Here, a cryogel‐based dendritic cell (DC) immunotherapy is developed incorporating gold nanodot‐lipopolysaccharide (AuLPS)‐loaded DCs, doxorubicin (Dox), and PD‐1 immune checkpoint blockade (aPD‐1+Dox+AuLPS@DC) to enhance post‐surgical antitumor immunity. The AuLPS nanoparticles (NPs) stabilize LPS assembly, optimizing Th1 adjuvant activity and improving DC immunotherapy efficacy while minimizing adverse effects. The cryogel enables the sustained, localized release of therapeutic agents at the surgical site, preserving DC viability, migration, and functionality within the tumor microenvironment. This strategy enhances DC activation and potentiates robust T‐cell activation in both tumor‐draining lymph nodes and tumor beds, leading to durable antitumor immunity. When administered at the post‐surgical site in an orthotopic TNBC model, the aPD‐1+Dox+AuLPS@DC cryogel immunotherapy significantly delays tumor recurrence, reduces distant metastasis, and prolongs survival. These findings highlight cryogel‐based DC immunotherapy as a promising post‐surgical therapeutic strategy to enhance responses to immune checkpoint blockade and improve outcomes in TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsImmunotherapyCryogelsTriple Negative Breast NeoplasmsAnimalsFemaleMiceHumansDoxorubicinCell Line, TumorImmune Checkpoint InhibitorsTumor Microenvironment

Stichwörter der Autor:innen

cryogeldendritic cell vaccineimmunotherapytriple‐negative breast cancer

Substanzen

CryogelsDoxorubicinImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan.
  • Department of Chemical Engineering, National Tsing Hua University, Hsinchu, 34881, Taiwan.
  • International Intercollegiate PhD Program, National Tsing Hua University, Hsinchu, 30013, Taiwan.
  • Institute of Translational Medicine and New Drug Development, School of Medicine, China Medical University, Taichung, 38019, Taiwan.
  • Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli, 35053, Taiwan.
  • Department of Chemistry, National Tsing Hua University, Hsinchu, 30013, Taiwan.

ORCID-Profile: Yunching Chen

Förderung

  • National Science and Technology Council
  • National Health Research Institutes
  • National Tsing Hua University
  • China Medical University

Zitieren

APA

Nguyen, L. D., Cheng, S. L., Yen, Y. T., Lee, H. M., Wu, T. H., Wang, J., Lin, S. Y., & Chen, Y. (2025). Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment. Advanced Science, 12(37). https://doi.org/10.1002/advs.202503238

Vancouver

Nguyen LD, Cheng SL, Yen YT, Lee HM, Wu TH, Wang J, et al. Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment. Advanced Science. 2025;12(37). doi:10.1002/advs.202503238

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Lam-Duc-Huy and Cheng, Sheng-Liang and Yen, Yu-Ting and Lee, Hsin-Mei and Wu, Te-Haw and Wang, Jane and Lin, Shu-Yi and Chen, Yunching},
  title = {Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {37},
  doi = {10.1002/advs.202503238}
}
Kostenlos starten →